XEROS TECHNOLOGY GROUP PLC Logo

XEROS TECHNOLOGY GROUP PLC

Develops and licenses polymer-based solutions that reduce industrial water consumption.

XSG | IL

Overview

Corporate Details

ISIN(s):
GB00BMGYBJ57
LEI:
2138009F3U39GVY7DG06
Country:
United Kingdom
Address:
UNIT 2, EVOLUTION ADVANCED MANUFACTURING PARK, S60 5BL ROTHERHAM

Description

Xeros Technology Group is a platform technology company that develops and licenses patented, polymer-based solutions designed to reduce the environmental impact of water-intensive industrial and commercial processes. The company's core technologies significantly decrease water and energy consumption in applications across the laundry, apparel manufacturing, and textile care industries. Key products derived from its platform include advanced laundry care systems, denim finishing systems that reduce chemical and water usage, and microfibre filtration systems that capture harmful microplastics released during washing cycles. Xeros licenses its innovations to manufacturers for integration into commercial and domestic appliances.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 14:20
TR-1 Entrepreneurs Fund
English 33.7 KB
2025-12-02 18:00
TR-1 Lombard Odier
English 50.9 KB
2025-12-02 15:40
TR-1 Dowgate
English 20.9 KB
2025-12-02 12:20
TR-1 Maven
English 21.0 KB
2025-11-28 12:15
Results of General Meeting and Director Dealings
English 43.3 KB
2025-11-27 13:40
Result of Follow-on Subscription and TVR
English 18.8 KB
2025-11-26 17:55
TR-1 Spreadex
English 22.3 KB
2025-11-11 14:25
Result of Retail Offer
English 26.4 KB
2025-11-07 11:25
Result of Fundraising
English 25.6 KB
2025-11-07 08:20
Retail Offer
English 40.7 KB
2025-11-06 19:45
Proposed Fundraise
English 279.1 KB
2025-10-24 16:07
Block listing Interim Review
English 14.2 KB
2025-10-14 18:11
TR-1 Maven
English 22.1 KB
2025-10-10 18:20
TR-1 Dowgate
English 22.0 KB
2025-10-09 15:05
TR-1 Spreadex
English 23.5 KB

Automate Your Workflow. Get a real-time feed of all XEROS TECHNOLOGY GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for XEROS TECHNOLOGY GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for XEROS TECHNOLOGY GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.